Published • loading... • Updated
'Objectively unreasonable’: Onego Bio slams The Every Co in high-stakes patent fight
Summary by AgFunderNews
1 Articles
1 Articles
'Objectively unreasonable’: Onego Bio slams The Every Co in high-stakes patent fight
Onego Bio—a startup producing egg proteins via precision fermentation—has launched legal action in a bid to invalidate a key patent granted to rival The Every Company. According to Onego Bio, The Every Co has demanded “unwarranted patent licensing fees” from Onego and engaged in tortious interference by telling third parties, including potential investors, that “Onego needs a patent license from Every or Onego would be infringing Every’s patents…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium